Tyr Pharma (ATYR) announced a publication demonstrating the mechanism of action for its lead therapeutic candidate, efzofitimod, in the ...
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback